Literature DB >> 7437797

Lymphocyte sensitisation in nifedipine-induced hepatitis.

A R Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7437797      PMCID： PMC1714796          DOI： 10.1136/bmj.281.6251.1354-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 3.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

4.  A case report of nifedipine-induced hepatitis with jaundice.

Authors:  Dimas Yusuf; Joanna Christy; David Owen; Meghan Ho; David Li; Martin J Fishman
Journal:  BMC Res Notes       Date:  2018-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.